TY - JOUR
T1 - Efficacy, safety and costs of intermittent presumptive treatment for malaria in tanzania
T2 - Beliefs, attitudes, experiences, and views of service providers and users
AU - Mubyazi, Godfrey Martin
AU - Bloch, Paul
AU - Magnussen, Pascal
AU - Byskov, Jens
AU - Hansen, Kristian Schultz
AU - Olsen, Øystein Evjen
AU - Mboera, Leonard E.G.
AU - Bygbjerg, Ib Christian
PY - 2010/12/1
Y1 - 2010/12/1
N2 - Introduction: Intermittent presumptive treatment (IPT) for malaria during pregnancy (IPTp) is advocated against malaria. Yet, concerns prevail regarding safety, efficacy, and costs of the recommended anti-malarial interventions in economic, social and multi-faceted health contexts. Objective: This chapter elucidates the views of frontline healthcare workers (HWs) and antenatal care (ANC) clients regarding feasibility of implementing anti-malarial drugs in formal healthcare settings of Tanzania, including the scaling-up IPTp delivery in attempt to attain higher population coverage. Emphasis is on efficacy, safety and cost issues related to SP for IPTp. Methods: Semi-structured interviews with HWs and pregnant women at ANC clinics and investigators' observations in the fields were conducted. Content analysis was done on qualitative information whereas quantitative data were analyzed using computer software programs. Results: The respondents expressed positive and negative attitudes towards IPTp currently in practice. The reported positives of IPTp were related to: sulfadoxine-pyrimethamine (SP) - a drug of choice being more efficacious than other anti-malarial drugs; easy deliverability in terms of users taking a full dose once; saving lives of women, fetuses and newborn babies; and un-bitter taste. The negatives include the: (i) perception about SP causing adverse treatment outcomes, this lowering users' adherence to treatment schedules, including directly observed treatment; (ii) perceived possible adverse reactions if SP is used by the users who take alcoholic drinks; (iii) increasing- parasites resistance to SP and HIV infections lowering public trust in SP; (iii) health facilities (HFs), especially the private ones facing SP shortages for free delivery, adding costs mainly to the service users and partly HWs who are forced to pay out of their pockets; (iv) HF-based IPTp services forcing pregnant women who reside far away to incur additional costs on re-visiting HFs, including the costs on transport, foods and/or drinks, besides purchasing SP elsewhere when the HFs concerned are out of stock of SP, and time lost for waiting for services. Moreover, user-fees for ANC services other than IPTp seemed to dissuade some potential clients to attend clinic. Additional findings and discussions are presented. Conclusion: When institutionalizing policies, national and international authorities sometimes under-rate the operational barriers to the recommended interventions in local settings. This study reveals that the social perceptions on- and the real deficiencies of anti-malarial drug efficacy, safety and costs are a challenge for rolling back malaria in Tanzania, as elsewhere in Africa.
AB - Introduction: Intermittent presumptive treatment (IPT) for malaria during pregnancy (IPTp) is advocated against malaria. Yet, concerns prevail regarding safety, efficacy, and costs of the recommended anti-malarial interventions in economic, social and multi-faceted health contexts. Objective: This chapter elucidates the views of frontline healthcare workers (HWs) and antenatal care (ANC) clients regarding feasibility of implementing anti-malarial drugs in formal healthcare settings of Tanzania, including the scaling-up IPTp delivery in attempt to attain higher population coverage. Emphasis is on efficacy, safety and cost issues related to SP for IPTp. Methods: Semi-structured interviews with HWs and pregnant women at ANC clinics and investigators' observations in the fields were conducted. Content analysis was done on qualitative information whereas quantitative data were analyzed using computer software programs. Results: The respondents expressed positive and negative attitudes towards IPTp currently in practice. The reported positives of IPTp were related to: sulfadoxine-pyrimethamine (SP) - a drug of choice being more efficacious than other anti-malarial drugs; easy deliverability in terms of users taking a full dose once; saving lives of women, fetuses and newborn babies; and un-bitter taste. The negatives include the: (i) perception about SP causing adverse treatment outcomes, this lowering users' adherence to treatment schedules, including directly observed treatment; (ii) perceived possible adverse reactions if SP is used by the users who take alcoholic drinks; (iii) increasing- parasites resistance to SP and HIV infections lowering public trust in SP; (iii) health facilities (HFs), especially the private ones facing SP shortages for free delivery, adding costs mainly to the service users and partly HWs who are forced to pay out of their pockets; (iv) HF-based IPTp services forcing pregnant women who reside far away to incur additional costs on re-visiting HFs, including the costs on transport, foods and/or drinks, besides purchasing SP elsewhere when the HFs concerned are out of stock of SP, and time lost for waiting for services. Moreover, user-fees for ANC services other than IPTp seemed to dissuade some potential clients to attend clinic. Additional findings and discussions are presented. Conclusion: When institutionalizing policies, national and international authorities sometimes under-rate the operational barriers to the recommended interventions in local settings. This study reveals that the social perceptions on- and the real deficiencies of anti-malarial drug efficacy, safety and costs are a challenge for rolling back malaria in Tanzania, as elsewhere in Africa.
KW - Accessibility
KW - Affordability
KW - Anti-malarial drugs
KW - Cost
KW - Healthcare
KW - Pregnancy
UR - http://www.scopus.com/inward/record.url?scp=84879812621&partnerID=8YFLogxK
M3 - Journal article
AN - SCOPUS:84879812621
SN - 1939-5906
VL - 1
SP - 383
EP - 412
JO - Journal of Malaria Research
JF - Journal of Malaria Research
IS - 3-4
ER -
